Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system

Cardiovascular Research

Volumn 73, Issue 2, 2007, Pages 288-297

  Fülöp, Norbert ^a   Marchase, Richard B ^b   Chatham, John C ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Diabetes; Hexosamine biosynthesis; O GlcNAc transferase; Protein O glycosylation

Indexed keywords

ANGIOTENSIN II; HEXOSAMINE; N ACETYLGLUCOSAMINE; PHENYLEPHRINE;

APOPTOSIS; BIOSYNTHESIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL FUNCTION; CELL LEVEL; CELL NUCLEUS; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CYTOPLASM; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GLYCOSYLATION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; MUSCLE RELAXATION; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

ACETYLGLUCOSAMINE; ANIMALS; CARDIOVASCULAR DISEASES; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLYCOSYLATION; HEXOSAMINES; HUMANS; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

EID: 33845582766     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.07.018     Document Type: Review

References (96)

1. Poornima I.G., Parikh P., and Shannon R.P. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 98 (2006) 596-605
2. Buse M.G. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 290 (2006) E1-E8
3. Slawson C., Housley M.P., and Hart G.W. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. J Cell Biochem 97 (2006) 71-83
4. Zachara N.E., and Hart G.W. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673 (2004) 13-28
5. Love D.C., and Hanover J.A. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005 (2005) re13
6. Marshall S., Bacote V., and Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266 (1991) 4706-4712
7. Kornfeld R. Studies on l-glutamine d-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J Biol Chem 242 (1967) 3135-3141
8. Cooksey R.C., and McClain D.A. Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance. Ann N Y Acad Sci 967 (2002) 102-111
9. Hebert L.F., Daniels M.C., Zhou J., Crook E.D., Turner R.L., Simmons S.T., et al. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98 (1996) 930-936
10. Virkamaki A., Daniels M.C., Hamalainen S., Utriainen T., McClain D., and Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology 138 (1997) 2501-2507
11. Virkamaki A., and Yki-Jarvinen H. Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetes 48 (1999) 1101-1107
12. Patti M.E., Virkamaki A., Landaker E.J., Kahn C.R., and Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48 (1999) 1562-1571
13. Sayeski P.P., and Kudlow J.E. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription. J Biol Chem 271 (1996) 15237-15243
14. Daniels M.C., McClain D.A., and Crook E.D. Transcriptional regulation of transforming growth factor beta1 by glucose: investigation into the role of the hexosamine biosynthesis pathway. Am J Med Sci 319 (2000) 138-142
15. Wang J., Liu R., Hawkins M., Barzilai N., and Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393 (1998) 684-688
16. Du X.L., Edelstein D., Rossetti L., Fantus I.G., Goldberg H., Ziyadeh F., et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97 (2000) 12222-12226
17. Vosseller K., Wells L., Lane M.D., and Hart G.W. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 99 (2002) 5313-5318
18. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
19. Kreppel L.K., Blomberg M.A., and Hart G.W. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 272 (1997) 9308-9315
20. Kreppel L.K., and Hart G.W. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J Biol Chem 274 (1999) 32015-32022
21. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 97 (2000) 5735-5739
22. Wells L., Kreppel L.K., Comer F.I., Wadzinski B.E., and Hart G.W. O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J Biol Chem 279 (2004) 38466-38470
23. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., and Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108 (2001) 1341-1348
24. Cheng X., Cole R.N., Zaia J., and Hart G.W. Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta. Biochemistry 9 (2000) 11609-11620
25. Kelly W.G., Dahmus M.E., and Hart G.W. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J Biol Chem 268 (1993) 10416-10424
26. Chou T.Y., Hart G.W., and Dang C.V. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270 (1995) 18961-18965
27. Haltiwanger R.S., Blomberg M.A., and Hart G.W. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. J Biol Chem 267 (1992) 9005-9013
28. Lubas W.A., Frank D.W., Krause M., and Hanover J.A. O-linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem 272 (1997) 9316-9324
29. Whelan S.A., and Hart G.W. Insulin increases tyrosine phosphorylation and activity of O-GlcNAc transferase (OGT). FASEB J 20 A955 (2006) (623.5)
30. Whisenhunt T.R., Yang X., Bowe D.B., Paterson A.J., Van Tine B.A., and Kudlow J.E. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16 (2006) 551-563
31. Dong D.L., and Hart G.W. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-d-glucosaminidase from rat spleen cytosol. J Biol Chem 269 (1994) 19321-19330
32. Wells L., Gao Y., Mahoney J.A., Vosseller K., Chen C., Rosen A., et al. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem 277 (2002) 1755-1761
33. Gao Y., Wells L., Comer F.I., Parker G.J., and Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J Biol Chem 276 (2001) 9838-9845
34. Toleman C., Paterson A.J., and Kudlow J.E. Location and characterization of the O-GlcNAcase active site. Biochim Biophys Acta 1760 (2006) 829-839
35. Toleman C., Paterson A.J., Whisenhunt T.R., and Kudlow J.E. Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J Biol Chem 279 (2004) 53665-53673
36. Shaw P., Freeman J., Bovey R., and Iggo R. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12 (1996) 921-930
37. Hanover J.A. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J 15 (2001) 1865-1876
38. Wells L., Whelan S.A., and Hart G.W. O-GlcNAc: a regulatory post-translational modification. Biochem Biophys Res Commun 302 (2003) 435-441
39. McClain D.A., Lubas W.A., Cooksey R.C., Hazel M., Parker G.J., Love D.C., et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci U S A 99 (2002) 10695-10699
40. Park S.Y., Ryu J., and Lee W. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Exp Mol Med 37 (2005) 220-229
41. Lehman D.M., Fu D.J., Freeman A.B., Hunt K.J., Leach R.J., Johnson-Pais T., et al. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-d glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 54 (2005) 1214-1221
42. Konrad R.J., Zhang F., Hale J.E., Knierman M.D., Becker G.W., and Kudlow JE. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun 293 (2002) 207-212
43. Liu K., Paterson A.J., Chin E., and Kudlow J.E. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc Natl Acad Sci U S A 97 (2000) 2820-2825
44. Tiedge M., Richter T., and Lenzen S. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase. Arch Biochem Biophys 375 (2000) 251-260
45. Macauley M.S., Whitworth G.E., Debowski A.W., Chin D., and Vocadlo D.J. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem 280 (2005) 25313-25322
46. Gao Y., Parker G.J., and Hart G.W. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells. Arch Biochem Biophys 383 (2000) 296-302
47. Federici M., Menghini R., Mauriello A., Hribal M.L., Ferrelli F., Lauro D., et al. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106 (2002) 466-472
48. Clark R.J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., et al. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 278 (2003) 44230-44237
49. Hu Y., Belke D., Suarez J., Swanson E., Clark R., Hoshijima M., et al. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ Res 96 (2005) 1006-1013
50. Borczuk A., and Factor S.M. Pathological Alterations of the Heart in Diabetes Mellitus. In: Chatham J.C., Forder J.R., and McNeill J.H. (Eds). The heart in diabetes (1996), Kluwer Academic Publishers, Norwell, MA 23-40
51. Asbun J., and Villarreal F.J. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47 (2006) 693-700
52. Ren J., and Davidoff A.J. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol Heart Circ Physiol 272 (1997) H148-H158
53. Davidoff A.J., and Ren J. Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 272 (1997) H159-H167
54. Dutta K., Carmody M.W., Cala S.E., and Davidoff A.J. Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy. J Mol Cell Cardiol 34 (2002) 985-996
55. Ren J., Gintant G.A., Miller R.E., and Davidoff A.J. High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Physiol Heart Circ Physiol 273 (1997) H2876-H2883
56. Pang Y., Bounelis P., Chatham J.C., and Marchase R.B. The hexosamine pathway is responsible for the inhibition by diabetes of phenylephrine-induced inotropy. Diabetes 53 (2004) 1074-1081
57. Liu J., Pang Y., Chang T., Bounelis P., Chatham J.C., and Marchase R.B. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol Cell Cardiol 40 (2006) 303-312
58. Kim Y.H., Song M., Oh Y.S., Heo K., Choi J.W., Park J.M., et al. Inhibition of phospholipase C-beta1-mediated signaling by O-GlcNAc modification. J Cell Physiol 207 (2006) 689-696
59. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., et al. Myocardial cell death in human diabetes. Circ Res 87 (2000) 1123-1132
60. Fiordaliso F., Li B., Latini R., Sonnenblick E.H., Anversa P., Leri A., et al. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab Invest 80 (2000) 513-527
61. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50 (2001) 2363-2375
62. Hennebicq-Reig S., Lesuffleur T., Capon C., De Bolos C., Kim I., Moreau O., et al. Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-d-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. Biochem J 334 Pt 1 (1998) 283-295
63. Gabriely I., Yang X.M., Cases J.A., Ma X.H., Rossetti L., and Barzilai N. Hyperglycemia modulates angiotensinogen gene expression. Am J Physiol Regul Integr Comp Physiol 281 (2001) R795-R802
64. Pang Y., Hunton D.L., Bounelis P., and Marchase R.B. Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes 51 (2002) 3461-3467
65. Hunton D.L., Lucchesi P.A., Pang Y., Cheng X., Dell'Italia L.J., and Marchase RB. Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes. J Biol Chem 277 (2002) 14266-14273
66. 2+ elevation in neonatal cardiomyocytes via protein-associated O-GlcNAc. Am J Physiol Cell Physiol 290 (2006) C57-C65
67. Slawson C., Zachara N.E., Vosseller K., Cheung W.D., Lane M.D., and Hart G.W. Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem 280 (2005) 32944-32956
68. Busk P.K., and Hinrichsen R. Cyclin D in left ventricle hypertrophy. Cell Cycle 2 (2003) 91-95
69. Azzarelli A., Dini F.L., Cristofani R., Giaconi A., Rossi A.M., Volterrani C., et al. NIDDM as unfavorable factor to the postinfarctual ventricular function in the elderly: echocardiography study. Coron Artery Dis 6 (1995) 629-634
70. Solomon S.D., St John Sutton M., Lamas G.A., Plappert T., Rouleau J.L., Skali H., et al. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Circulation 106 (2002) 1251-1255
71. Bell D.S. Diabetic cardiomyopathy. Diabetes Care 26 (2003) 2949-2951
72. James L.R., Tang D., Ingram A., Ly H., Thai K., Cai L., et al. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation. Diabetes 51 (2002) 1146-1156
73. Kneass Z.T., and Marchase R.B. Neutrophils exhibit rapid agonist-induced increases in protein-associated O-GlcNAc. J Biol Chem 279 (2004) 45759-45765
74. Hall J.L., Chatham J.C., Eldar-Finkelman H., and Gibbons G.H. Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis: role of GSK3β. Diabetes 50 (2001) 1171-1179
75. Lubas W.A., and Hanover J.A. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J Biol Chem 275 (2000) 10983-10988
76. Luscher T.F., Tanner F.C., Tschudi M.R., and Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 44 (1993) 395-418
77. Makimattila S., Virkamaki A., Groop P.H., Cockcroft J., Utriainen T., Fagerudd J., et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 94 (1996) 1276-1282
78. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
79. Tsikouris J.P., Suarez J.A., and Meyerrose G.E. Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents. J Clin Pharmacol 42 (2002) 1187-1199
80. Goldberg H.J., Whiteside C.I., Hart G.W., and Fantus I.G. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology 147 (2006) 222-231
81. Kolm-Litty V., Sauer U., Nerlich A., Lehmann R., and Schleicher E.D. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101 (1998) 160-169
82. James L.R., Fantus I.G., Goldberg H., Ly H., and Scholey J.W. Overexpression of GFAT activates PAI-1 promoter in mesangial cells. Am J Physiol Renal Physiol 279 (2000) F718-F727
83. Hosomi N., Noma T., Ohyama H., Takahashi T., and Kohno M. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Atherosclerosis 162 (2002) 69-76
84. Zachara N.E., O'Donnell N., Cheung W.D., Mercer J.J., Marth J.D., and Hart G.W. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 279 (2004) 30133-30142
85. Sohn K.C., Lee K.Y., Park J.E., and Do S.I. OGT functions as a catalytic chaperone under heat stress response: a unique defense role of OGT in hyperthermia. Biochem Biophys Res Commun 322 (2004) 1045-1051
86. Champattanachai V, Chatham, JC, Marchase, RB. Increased Flux through the hexosamine biosynthesis pathway protects cardiomyocytes from ischemia-reperfusion injury. Am J Physiol, Cell Physiol. doi:10.1152/ajpcell.00162.2006.
87. Yang S., Zou L., Bounelis P.I.C., Chatham J.C., and Marchase R.B. Glucosamine administration during resuscitation improves organ function following trauma-hemorrhage. Shock 25 (2006) 600-607
88. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow JE. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
89. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J Med 338 (1998) 171-179
90. D'Alessandris C., Andreozzi F., Federici M., Cardellini M., Brunetti A., Ranalli M., et al. Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells. FASEB J 18 (2004) 959-961
91. Buse M.G., Robinson K.A., Marshall B.A., Hresko R.C., and Mueckler M.M. Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles. Am J Physiol Endocrinol Metab 283 (2002) E241-E250
92. Gandy J.C., Rountree A.E., and Bijur G.N. Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1. FEBS Lett 580 (2006) 3051-3058
93. Parker G., Taylor R., Jones D., and McClain D. Hyperglycemia and inhibition of glycogen synthase in streptozotocin-treated mice: role of O-linked N-acetylglucosamine. J Biol Chem 279 (2004) 20636-20642
94. Parker G.J., Lund K.C., Taylor R.P., and McClain DA. Insulin resistance of glycogen synthase mediated by O-linked N-acetylglucosamine. J Biol Chem 278 (2003) 10022-10027
95. Kolm-Litty V., Tippmer S., Haring H.U., and Schleicher E. Glucosamine induces translocation of protein kinase C isoenzymes in mesangial cells. Exp Clin Endocrinol Diabetes 106 (1998) 377-383
96. Matthews J.A., Acevedo-Duncan M., and Potter R.L. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells. Biochim Biophys Acta 1743 (2005) 305-315